AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇼
CIPROFLOXACIN in Zimbabwe
5 products registered with MCAZ — 5 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| ZOXAN FLOXAN SOLUTION/DROPS; OPHTHALMIC | 2015/19.11/5066 | FDC LIMITED | active | 28 Aug 2029 |
| CIPROBAY TABLET; ORAL | 94/7.2.5/2874 | BAYER (PTY) LTD | active | 31 Dec 2027 |
| CIPROBAY SUSPENSION GRANULE, FOR SUSPENSION; ORAL | 2018/7.2.5/5544 | BAYER (PTY) LTD | active | 31 Dec 2027 |
| CILOXAN SOLUTION/DROPS; OPHTHALMIC | 99/19.1.1/3585 | NOVARTIS SOUTH AFRICA (PTY) LTD | active | 31 Dec 2027 |
| TYFLOX-500 TABLET, COATED; ORAL | 2009/7.2.5/4565 | AJANTA PHARMA | active | 31 Dec 2027 |
CIPROFLOXACIN — MCAZ Registration Details
MCAZ (Zimbabwe) has 5 registered products containing CIPROFLOXACIN, of which 5 are currently active. Data is sourced directly from the official MCAZ drug register and refreshed daily.
Track CIPROFLOXACIN registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.